[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339935-105":59,"doc-detail-339935-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-susceptibility-gene-signature-for-erbb2-driven-mammary-tumour-development-and-metastasis-in-collaborative-cross-mice-research-findings","A susceptibility gene signature for ERBB2-driven mammary tumour development and metastasis in collaborative cross mice - Research findings","","A study investigates genetic determinants of ERBB2-driven mammary tumour development and metastasis using the Collaborative Cross (CC) mouse model. Researchers monitored 732 F1 hybrid female mice and applied GWAS, multivariate modeling, and polygenic approaches to construct a mouse tumour susceptibility gene signature (mTSGS) and its human ortholog (hTSGS). Findings link specific SNPs and 20 genes to tumour onset, multiplicity, and metastatic patterns, with hTSGS showing prognostic and chemotherapy-response predictive value across human breast cancer cohorts and validation in vivo.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-susceptibility-gene-signature-for-erbb2-driven-mammary-tumour-development-and-metastasis-in-collaborative-cross-mice-research-findings/339935/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-susceptibility-gene-signature-for-erbb2-driven-mammary-tumour-development-and-metastasis-in-collaborative-cross-mice-research-findings/339935.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What model was used to discover genetic factors for ERBB2-driven tumours?","Question",{"text":112,"@type":113},"The Collaborative Cross (CC) mouse model was used with 732 F1 hybrid female mice derived from FVB/N MMTV-Erbb2 and 30 CC strains.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the tumour susceptibility gene signatures constructed?",{"text":117,"@type":113},"GWAS identified SNPs linked to tumour phenotypes, and multivariate analyses built a mouse tumour susceptibility gene signature (mTSGS), mapping to a human ortholog termed hTSGS.",{"name":119,"@type":110,"acceptedAnswer":120},"Does the human signature predict prognosis and treatment response?",{"text":121,"@type":113},"hTSGS scores showed prognostic value across multiple human breast cancer cohorts and predicted pathological complete response in the I-SPY2 study, outperforming or exceeding other clinical measures; mouse validation supported chemotherapy-response prediction.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339935,1790192644,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Articles   \nA susceptibility gene signature for ERBB2-driven mammary tumour development and metastasis in collaborative cross mice  \nHui Yang,a,j Xinzhi Wang,a,k Adrián Blanco-Gómez,b,c Li He,a,d Natalia García-Sancha,b,c Roberto Corchado-Cobos,b,c Manuel Jesús Pérez-Baena,b,c Alejandro Jiménez-Navas,b,c Pin Wang,a,e Jamie L. Inman,a Antoine M. Snijders,a,f David W. Threadgill,g,h Allan Balmain,i Hang Chang,a,f,∗∗ Jesus Perez-Losada,b,c,∗ and Jian-Hua Maoa,f,∗∗∗  \naBiological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA  \nbInstituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, 37007, Spain cInstituto de Investigación Biosanitaria de Salamanca (IBSAL), Salamanca, 37007, Spain  \ndDepartment of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430079, China  \neDepartment of Gastroenterology, Nanjing Drum Tower Hospital, Afﬁliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, 210008, China  \nfBerkeley Biomedical Data Science Center, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA gDepartment of Nutrition, Texas A&M University, College Station, TX, 77843, USA  \nhDepartment of Molecular and Cellular Medicine and Department of Biochemistry & Biophysics, Texas A&M University, College Station, TX, 77843, USA  \niHelen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, 94158, USA  \nSummary  \nBackground Deeper insights into ERBB2-driven cancers are essential to develop new treatment approaches for ERBB2+ breast cancers (BCs) . We employed the Collaborative Cross (CC) mouse model to unearth genetic factors underpinning Erbb2-driven mammary tumour development and metastasis.  \nMethods 732 F1 hybrid female mice between FVB/N MMTV-Erbb2 and 30 CC strains were monitored for mammary tumour phenotypes. GWAS pinpointed SNPs that inﬂuence various tumour phenotypes. Multivariate analyses and models were used to construct the polygenic score and to develop a mouse tumour susceptibility gene signature (mTSGS), where the corresponding human ortholog was identiﬁed and designated as hTSGS. The importance and clinical value of hTSGS in human BC was evaluated using public datasets, encompassing TCGA, METABRIC, GSE96058, and I-SPY2 cohorts. The predictive power of mTSGS for response to chemotherapy was validated in vivo using genetically diverse MMTV-Erbb2 mice.  \nFindings Distinct variances in tumour onset, multiplicity, and metastatic patterns were observed in F1-hybrid female mice between FVB/N MMTV-Erbb2 and 30 CC strains. Besides lung metastasis, liver and kidney metastases emerged in speciﬁc CC strains. GWAS identiﬁed speciﬁc SNPs signiﬁcantly associated with tumour onset, multiplicity, lung metastasis, and liver metastasis. Multivariate analyses ﬂagged SNPs in 20 genes (Stx6, Ramp1, Traf3ip1, Nckap5, Pfkfb2, Trmt1l, Rprd1b, Rer1, Sepsecs, Rhobtb1, Tsen15, Abcc3, Arid5b, Tnr, Dock2, Tti1, Fam81a, Oxr1, Plxna2, and Tbc1d31) independently tied to various tumour characteristics, designated as a mTSGS. hTSGS scores (hTSGSS) based on their transcriptional level showed prognostic values, superseding clinical factors and PAM50 subtype across multiple human BC cohorts, and predicted pathological complete response independent of and superior to MammaPrint score in I-SPY2 study. The power of mTSGS score for predicting chemotherapy response was further validated in an in vivo mouse MMTV-Erbb2 model, showing that, like ﬁndings in human patients, mouse tumours with low mTSGS scores were most likely to respond to treatment.  \n*Corresponding author. Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, 37007, Spain.  \n**Corresponding author. Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.  \n***Corresponding author. Biological Systems and Engineering Division, La","cbCaihLBuY2AbH7e","https://ap.wps.com/l/cbCaihLBuY2AbH7e","pdf",1919656,13,"English","# Background\n## Methods\n## Findings\n## Interpretation\n## Funding\n## Keywords","[{\"question\":\"What model was used to discover genetic factors for ERBB2-driven tumours?\",\"answer\":\"The Collaborative Cross (CC) mouse model was used with 732 F1 hybrid female mice derived from FVB/N MMTV-Erbb2 and 30 CC strains.\"},{\"question\":\"How were the tumour susceptibility gene signatures constructed?\",\"answer\":\"GWAS identified SNPs linked to tumour phenotypes, and multivariate analyses built a mouse tumour susceptibility gene signature (mTSGS), mapping to a human ortholog termed hTSGS.\"},{\"question\":\"Does the human signature predict prognosis and treatment response?\",\"answer\":\"hTSGS scores showed prognostic value across multiple human breast cancer cohorts and predicted pathological complete response in the I-SPY2 study, outperforming or exceeding other clinical measures; mouse validation supported chemotherapy-response prediction.\"}]","A susceptibility gene signature for ERBB2-driven mammary tumour development and metastasis in collaborative cross mice - Research findings | PDF",1790033187,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f3c0c174520c79d6771a6fd4d018c6df.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/217464515531a874bbbc4621512d9926.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/15631fcea38b42b837befde2fc939cf0.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9fe7c47d4966493766992bbccdd0a12f.webp",980,1306]